Publications by authors named "Matthew Luzentales-Simpson"

Claim this Profile
B
Bespoke plant glycoconjugates for gut microbiota-mediated drug targeting.
Wei Jen Ma, Changqing Wang, Jagatheeswaran Kothandapani, Matthew Luzentales-Simpson, Susan C Menzies

Science· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring person-centred care in the mission, vision, and core value statements of Canadian healthcare organizations.
Iqmat Iyiola, Sadia Ahmed, Paul Fairie, Matthew Luzentales-Simpson, Kimberly Manalili

BMC Health Serv Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vedolizumab: Potential Mechanisms of Action for Reducing Pathological Inflammation in Inflammatory Bowel Diseases.
Matthew Luzentales-Simpson, Yvonne C F Pang, Ada Zhang, James A Sousa, Laura M Sly

Front Cell Dev Biol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repression of phagocytosis by human CD33 is not conserved with mouse CD33.
Abhishek Bhattacherjee, Emily Rodrigues, Jaesoo Jung, Matthew Luzentales-Simpson, Jhon R Enterina

Commun Biol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Author Correction: Repression of phagocytosis by human CD33 is not conserved with mouse CD33.
Abhishek Bhattacherjee, Emily Rodrigues, Jaesoo Jung, Matthew Luzentales-Simpson, Jhon R Enterina

Commun Biol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis